title: The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs.
abstract: BACKGROUND
  Hypertension and proteinuria are commonly recognized in dogs with spontaneous hypercortisolism. There is, however, little information regarding the effect of exogenous glucocorticoids on blood pressure (BP) and proteinuria and whether these changes are reversible.
  
  
  OBJECTIVE
  Hydrocortisone administration increases systemic BP and urinary protein excretion, and these effects are reversible after hydrocortisone withdrawal.
  
  
  METHODS
  Six control dogs and 6 dogs treated with hydrocortisone.
  
  
  METHODS
  BP, urine protein : creatinine ratio (UPC), microalbuminuria (MALB), urine albumin : creatinine ratio (UAC), and urine gel electrophoresis were evaluated before, during, and after administration of hydrocortisone (8 mg/kg PO q12h for 12 weeks) or placebo.
  
  
  RESULTS
  BP and UPC increased substantially during hydrocortisone administration from 123 mmHg (range 114-136 mmHg) and 0.17 (0.15-0.28) to a maximum of 143 mmHg (128-148 mmHg) and 0.38 (0.18-1.78), respectively, on day 28. MALB developed in 4 dogs and UAC significantly increased in all dogs during hydrocortisone administration with the maximum on day 84. Both increases in BP and proteinuria were reversible and completely resolved within 1 month after stopping hydrocortisone administration. SDS-AGE revealed the proteinuria to be primarily albuminuria with a pronounced increase during hydrocortisone treatment. Furthermore, a protein of 25-30 kDa was found in male dogs, identified by mass spectrometry to be arginine esterase, the major secretory prostatic protein.
  
  
  CONCLUSIONS
  Long-term hydrocortisone treatment results in significant but only mild increases in systemic BP and urinary protein excretion, which are both reversible within 1 month after discontinuation of hydrocortisone.
authors.affiliation: Clinic for Small Animal Internal, Medicine, Vetsuisse Faculty University of Zurich, Winterthurerstr, Zurich, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Schellenberg
authors.forename: M
authors.initials: M
authors.lastname: Mettler
authors.forename: F
authors.initials: F
authors.lastname: Gentilini
authors.forename: R
authors.initials: R
authors.lastname: Portmann
authors.forename: T M
authors.initials: TM
authors.lastname: Glaus
authors.forename: C E
authors.initials: CE
authors.lastname: Reusch
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004283:Dog Diseases / Q000139:chemically induced*; D004285:Dogs; D005260:Female; D006854:Hydrocortisone / Q000494:pharmacology*; D006973:Hypertension / Q000139:chemically induced / Q000662:veterinary*; D008297:Male; D011507:Proteinuria / Q000139:chemically induced / Q000662:veterinary*
chemical_list: D006854:Hydrocortisone